Daniel J Drucker
@danieljdrucker
A clinician scientist at LTRI @sinaihealth studying GLP-1, diabetes, obesity and the gut endocrine system Proud 🇨🇦Not going anywhere Am 🇮🇱Chai
ID: 292334056
http://glucagon.com 03-05-2011 13:51:01
31,31K Tweet
32,32K Takipçi
1,1K Takip Edilen
GLP-1 medicines produce adverse events, predominantly gastrointestinal, transient in most. Yet controversy continues surrounding what AEs are rare but real vs. alleged but not rigorously proven in RCTs or real world data. Free to read Diabetes Care, a research journal of the ADA 🌟 diabetesjournals.org/care/article/d…
